Functionally, GSEA revealed that PLXNA3 expression in COAD is negatively associated with pathways such as Interferon Gamma Response, Oxidative Phosphorylation, and Inflammatory Response, which are central to T cell activation and recruitment (48–50). Here, PLXNA3 is linked to colon adenocarcinoma.